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DispensationIntroduction: Nontuberculous mycobacterium (NTM) has clinical and radiological manifes-
tations that are indistinguishable from mycobacterium tuberculosis (MTB). In an endemic
area for tuberculosis (TB), limited data about prevalence and outcome of treatment of these
patients is available.
In this study the prevalence of different types of mycobacterium and response to treat-
ment in a tertiary referral center in Iran will be evaluated.
Materials and method: All NTM cases from 2004 to 2013 at the National Research Institute of
Tuberculosis and Lung Diseases (NRITLD) in Iran were extracted from the database. All
NTM patients who were treated for NTM diseases entered this study, and the outcome of
treatment was evaluated.
Results: A total of 104 cases were detected. The mean age was 56.34 ± 15.77 years. Half of
the patients were male. Most of the patients had a history of prior TB treatment. The most
common types of NTM were Mycobacterium simiae (44 [42.3%]), Mycobacterium kansasii (18
[17.3%]), Mycobacterium abcessus (15 [14.4%]), andMycobacterium chelonea (14 [13.5%]), respec-
tively.
The outcome of treatment was as follows: cure 61 (58.7%), failure 17 (16.3%), relapse 3
(2.9%), default 13 (12.5%) and death in 10 (9.6%) patients.
Conclusion: Treatment of NTM had a low cure rate despite low mortality.
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